Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP587942.RAndeQ_-wUG4zcndP8jtgU6R7b-OMHnrTS8r1B4_XabeQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP587942.RAndeQ_-wUG4zcndP8jtgU6R7b-OMHnrTS8r1B4_XabeQ130_assertion type Assertion NP587942.RAndeQ_-wUG4zcndP8jtgU6R7b-OMHnrTS8r1B4_XabeQ130_head.
- NP587942.RAndeQ_-wUG4zcndP8jtgU6R7b-OMHnrTS8r1B4_XabeQ130_assertion description "[A human ovarian cancer cell line, 1A9-L4 (L4), previously selected in high concentrations of laulimalide, has both a single point mutation in ?I-tubulin and overexpression of ?II- and ?III-tubulin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587942.RAndeQ_-wUG4zcndP8jtgU6R7b-OMHnrTS8r1B4_XabeQ130_provenance.
- NP587942.RAndeQ_-wUG4zcndP8jtgU6R7b-OMHnrTS8r1B4_XabeQ130_assertion evidence source_evidence_literature NP587942.RAndeQ_-wUG4zcndP8jtgU6R7b-OMHnrTS8r1B4_XabeQ130_provenance.
- NP587942.RAndeQ_-wUG4zcndP8jtgU6R7b-OMHnrTS8r1B4_XabeQ130_assertion SIO_000772 22180309 NP587942.RAndeQ_-wUG4zcndP8jtgU6R7b-OMHnrTS8r1B4_XabeQ130_provenance.
- NP587942.RAndeQ_-wUG4zcndP8jtgU6R7b-OMHnrTS8r1B4_XabeQ130_assertion wasDerivedFrom befree-20150227 NP587942.RAndeQ_-wUG4zcndP8jtgU6R7b-OMHnrTS8r1B4_XabeQ130_provenance.
- NP587942.RAndeQ_-wUG4zcndP8jtgU6R7b-OMHnrTS8r1B4_XabeQ130_assertion wasGeneratedBy ECO_0000203 NP587942.RAndeQ_-wUG4zcndP8jtgU6R7b-OMHnrTS8r1B4_XabeQ130_provenance.